NICE says more evidence needed for newer UTI point-of-care tests Several newer point-of-care tests were not recommended in latest guidance from the National Institute for Health and Care Excellence, in which it concluded that more research needs to be carried out on their accuracy.…
Thousands of NHS patients with prostate or breast cancer eligible for new targeted treatment NHS England says around 800 people in England could be eligible for olaparib treatment each year.…
NICE approves new drug for chronic kidney disease and diabetes Results from a phase III study of more than 5,000 adults suggested that finerenone improved kidney function and helped slow the worsening of chronic kidney disease.…
NICE confirms recommendation for NHS use of three COVID-19 treatments Final guidance published by the National Institute for Health and Care Excellence recommends nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for COVID-19.…
Four point-of-care tests for UTIs ‘show promise’, says NICE in early guidance NICE said it needs more data on the accuracy of the tests in detecting and identifying bacteria before it can recommend them for use in the NHS.…
Weight loss drug semaglutide will ‘soon’ be available to eligible patients, says NICE Trial results showed that participants taking semaglutide lost an average of 12% more of their body weight compared with placebo.…
Apps for treatment of anxiety and depression in adults provisionally approved by NICE The eight digital therapies include treatments for body dysmorphic disorder and post-traumatic stress disorder.…
NICE alters guidance on COVID-19 treatments as manufacturer withdraws marketing authorisation application The National Institute of Health and Care Excellence said the guidance has changed because Eli Lily is no longer seeking a marketing authorisation for baricitinib (Olumiant).…
UTIs can be diagnosed without a dipstick test, says NICE The National Institute for Health and Care Excellence has said women aged under 65 years can be diagnosed with urinary tract infection if they have two or more key urinary symptoms and no other excluding causes or warning signs.…
Alternative to injections for people with severe migraines approved for use on NHS Eptinezumab, a calcitonin gene-related peptide inhibitor, will be available on the NHS for people with episodic and chronic migraines who meet certain conditions.…